S2Medical AB (S2M) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.031x

Based on the latest financial reports, S2Medical AB (S2M) has a cash flow conversion efficiency ratio of -0.031x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-306.89K ≈ $-33.03K USD) by net assets (Skr9.87 Million ≈ $1.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see S2Medical AB (S2M) market capitalisation for the company's overall valuation and market capitalisation.

S2Medical AB - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how S2Medical AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

S2Medical AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of S2Medical AB ranked by their cash flow conversion efficiency. Explore cash flow quality index of S2Medical AB to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Faron Pharmaceuticals Oy
LSE:FARN
0.000x
Watkin Jones PLC
LSE:WJG
-0.050x
Churchill China plc
LSE:CHH
0.013x
IMMERSION G. S.A. ZY 10
F:73W
3.367x
Craven House Capital PLC
LSE:CRV
0.000x
Alkemy Capital Investments Plc
LSE:ALK
1.013x
STMicroelectronics NV
LSE:0INB
0.221x
Aequus Pharmaceuticals Inc
V:AQS
0.003x

Annual Cash Flow Conversion Efficiency for S2Medical AB (2016–2025)

The table below shows the annual cash flow conversion efficiency of S2Medical AB from 2016 to 2025. View S2M share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr9.87 Million
≈ $1.06 Million
Skr675.00K
≈ $72.64K
0.068x -83.96%
2024-12-31 Skr11.80 Million
≈ $1.27 Million
Skr5.03 Million
≈ $541.40K
0.426x +104.28%
2023-12-31 Skr1.66 Million
≈ $178.42K
Skr-16.52 Million
≈ $-1.78 Million
-9.964x -150.39%
2022-12-31 Skr7.07 Million
≈ $760.76K
Skr-28.13 Million
≈ $-3.03 Million
-3.979x -197.08%
2021-12-31 Skr14.68 Million
≈ $1.58 Million
Skr-19.67 Million
≈ $-2.12 Million
-1.339x -244.25%
2020-12-31 Skr32.77 Million
≈ $3.53 Million
Skr-12.75 Million
≈ $-1.37 Million
-0.389x +42.87%
2019-12-31 Skr25.11 Million
≈ $2.70 Million
Skr-17.10 Million
≈ $-1.84 Million
-0.681x -132.57%
2018-12-31 Skr43.55 Million
≈ $4.69 Million
Skr-12.75 Million
≈ $-1.37 Million
-0.293x +63.05%
2017-12-31 Skr7.38 Million
≈ $793.67K
Skr-5.85 Million
≈ $-629.12K
-0.793x +28.05%
2016-12-31 Skr2.75 Million
≈ $296.05K
Skr-3.03 Million
≈ $-326.18K
-1.102x --

About S2Medical AB

ST:S2M Sweden Medical Instruments & Supplies
Market Cap
$483.55K
Skr4.49 Million SEK
Market Cap Rank
#31076 Global
#729 in Sweden
Share Price
Skr0.01
Change (1 day)
-3.85%
52-Week Range
Skr0.00 - Skr0.01
All Time High
Skr1000000.00
About

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and… Read more